Filing Flows › Comparisons › ELAN vs JAZZ
Elanco Animal Health vs Jazz Pharmaceuticals: ELAN and JAZZ compared
Elanco Animal Health is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $1.2B for Jazz Pharmaceuticals (Q3 2026). Elanco Animal Health is growing faster (+11% against +10% a year earlier). Elanco Animal Health is more profitable, with an operating margin of 1.9% against -33.3%.
Where the money goes: ELAN and JAZZ
Elanco Animal Health (ELAN) · Q3 2026
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
Jazz Pharmaceuticals (JAZZ) · Q3 2026
Jazz Pharmaceuticals, Q3 2026: revenue $1.2B (+10% year over year), operating margin -33.3%, net loss $483M, operating cash flow $506M. The chart follows the revenue to costs, profit and cash.
| Elanco Animal Health (ELAN) | Jazz Pharmaceuticals (JAZZ) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.3B | $1.2B |
| Revenue growth, Y/Y | +11% | +10% |
| Gross margin | 56.9% | — |
| Operating margin | 1.9% | -33.3% |
| Net earnings | $18.0M | −$483M |
| Net margin | 1.4% | -38.9% |
| Operating cash flow | $216M | $506M |
| Free cash flow | $156M | $490M |
| Market value | $13.1B | $15.2B |
| P/E | — | 76.5× |
| Analysts’ mean target | $30.69 | $296.27 |
Where the revenue comes from
Elanco Animal Health
- Farm Animal:: $631M (50%)
- Pet Health: $608M (48%)
- Contract Manufacturing: $26.0M (2%)
Jazz Pharmaceuticals
- Sleep: $514M (41%)
- Xywav: $482M (39%)
- Rylaze/Enrylaze: $106M (9%)
- Zepzelca: $104M (8%)
Questions
Which is bigger, Elanco Animal Health or Jazz Pharmaceuticals?
Elanco Animal Health is the larger company: $1.3B of revenue in its latest quarter (Q3 2026) against $1.2B for Jazz Pharmaceuticals (Q3 2026).
Is Elanco Animal Health or Jazz Pharmaceuticals growing faster?
Elanco Animal Health is growing faster (+11% against +10% a year earlier).
Which is more profitable, Elanco Animal Health or Jazz Pharmaceuticals?
Elanco Animal Health is more profitable, with an operating margin of 1.9% against -33.3%.
More: Elanco Animal Health earnings · how Elanco Animal Health makes money · Jazz Pharmaceuticals earnings · how Jazz Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.